Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Zura Bio Ltd (ZURA) Cash Flow Statement

Zura Bio Ltd (ZURA) generated -$64.8M of operating cash flow over the twelve months to 2026-06-30, spent $112973 on capital expenditure and had free cash flow of -$64.9M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ZURAZura Bio LtdFollow ZURA — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
322.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
18 Nov, in 25 days
LineFY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-1.1-15.1-28.1-64.8-64.8
Capital expenditure——0.10.1-0.1
Free cash flow——-28.2-64.9-64.9
Stock-based compensation—7.516.812.3—

USD millions · SEC XBRL

Zura Bio Ltd — questions

What is Zura Bio Ltd's operating cash flow?
-$64.8M over the twelve months to 2026-06-30.
How much does Zura Bio Ltd spend on capital expenditure?
$112973 over the twelve months to 2026-06-30.
What is Zura Bio Ltd's free cash flow?
-$64.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Zura Bio Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.